In addition to acting through the p38 pathway, GLP-1RAs also promote the increase of PKA levels via the cAMP-dependent pathway, which in turn prevents the phosphorylation of epidermal growth factor receptor (EGFR) and activator of transcription 3 (STAT3), resulting in the inactivation of the EGFR-STAT3 signaling pathway in tumor cells and subsequently downregulating several downstream effector genes such as myelocytomatosis oncogene (c-Myc), survivin, cyclin D1, Bcl-xl, and Bcl-2, thereby inducing apoptosis in tumor cells in a dose-dependent manner [70, 73]
Extended use beyond 24 weeks has not been studied in the context of athletic performance
It is a structural feature of the MLM model
When fat is repositioned or transposed, there is also a risk of irregular contouring or asymmetry
You should always discuss potential side effects with your physician to ensure the medication is suitable and right for you